DiscoverThe Third WaveDanny Motyka - Chemistry, Biosynthetics, and the Promise of Novel Psychedelic Medicines
Danny Motyka - Chemistry, Biosynthetics, and the Promise of Novel Psychedelic Medicines

Danny Motyka - Chemistry, Biosynthetics, and the Promise of Novel Psychedelic Medicines

Update: 2020-12-20
Share

Description

With a decades-long commitment to psychedelic advocacy and research, a firsthand knowledge of the life-changing benefits of plant medicine, and his role as CEO of Psygen Labs, Danny Motyka brings a unique perspective to the future of psychedelics. In this episode, he and Paul discuss the differences between the cannabis and psychedelic industries, the role of plant medicines as preventative treatments, and what psychedelic therapy might look like in the near future.

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Danny Motyka - Chemistry, Biosynthetics, and the Promise of Novel Psychedelic Medicines

Danny Motyka - Chemistry, Biosynthetics, and the Promise of Novel Psychedelic Medicines

Third Wave